HealthScout Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 
 
 Printer Friendly  Send to a Friend

Primary Tumors Fuel Growth of Cancer Cells

Finding suggests interception of this signal may thwart metastases, study says


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
Study Suggests Red Wine May Protect Against Lung Cancer
Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer
Scientists Explore New Test for Down Syndrome
Prostate Meds Not Tied to Increased Hip Fracture Risk
More...

THURSDAY, June 12 (HealthDay News) -- Primary tumors can fuel the growth of stray cancer cells elsewhere in the body, say researchers at the Massachusetts Institute of Technology.

In experiments with mice, the MIT team found that primary tumors derived from human breast cancers seem to promote the growth of distant cancers by mobilizing bone marrow cells, which then feed the growth of the secondary tumors.

Text Continues Below



The secretion of a substance called osteopontin by the primary tumor is an important part of this process, said the researchers, who noted that osteopontin is present at elevated levels in women with metastatic breast cancer.

While the researchers found that the primary tumor somehow disturbs the make-up of bone marrow, they don't know exactly how that occurs. They also know that osteopontin does not act alone in this process.

The findings, published in the June 13 issue of Cell, may lead to new cancer treatments.

"If metastases depend on stimulation by primary tumors, interception of the signal through neutralizing antibodies," may prevent the spread of cancer, researcher Robert Weinberg said in a prepared statement. "That's still speculative, but it's an interesting idea to ponder."

He noted that current treatments don't specifically target metastases, which causes the vast majority of cancer deaths.

The findings may also prove important for the pre-clinical study of cancers.

"The ability of instigating tumors to foster the growth of a human colon tumor surgical specimen underscores the power of systemic instigation," Weinberg and colleagues wrote. "Indeed, to our knowledge, methods to expedite the growth of human tumor surgical specimens in vivo have not been previously described. These results suggest that the presently described procedure can be used to study aspects of human tumor biology that would otherwise be difficult if not impossible to study."

More information

The National Cancer Institute has more about metastatic cancer.



-- Robert Preidt

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 6/12/2008

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates




SOURCE: Cell Press, news release, June 12, 2008


Healthscout Search
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Resources
Healthscout News
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
Newsletter Subscription
News Archive
PR Newswire News Video Releases
Privacy Policy

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service